Monday, 10 Dec 2018

Biologic/Novel Rx

Datesort ascending Type Title Save
28 Aug 2017 News Canakinumab Reduces CV Outcomes in High Risk Patients
28 Aug 2017 Social RT @DanielHSolomon: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease — NEJM how will this affect rheumatology? https:/…
22 Aug 2017 Social RT @RheumKay: What's harder than making copycat biotech drugs? Selling them https://t.co/gMHACs9RpN via @markets
22 Aug 2017 Social Korean companies Celltrion & Samsung Bioepis have exported $1.63 Billion in Biosimilars in 2016. https://t.co/JHBQqJSV6h
21 Aug 2017 Social Ironwood announces FDA approval of its combo drug lesinurad/allopurinol in a 200/300 tablet. Could this be useful? https://t.co/lcUZTieKqg
21 Aug 2017 Social FDA CDER list of licensed biologics and biosimilars updated Aug 2017 https://t.co/bIFmjPsId7
19 Aug 2017 Social RheumNow Wk in Review up! How to store enbrel, over/under testing. Check out podcast https://t.co/I5b8tFK7Oa video https://t.co/rJ2nMY6woD
14 Aug 2017 Social Tocilizumab in Scleroderma completed enrollment in phase III trial - another yr till skin + lung results https://t.co/6QVGeDScbv
08 Aug 2017 Social Tanezumab (MAb against nerve growth factor) is being fast-tracked by FDA as a non-opioid pain reliever. https://t.co/ZXJnS7CmE4
08 Aug 2017 News Therapeutic Update: 5 Questions on Sirukumab FDA Hearing
06 Aug 2017 Social When biosimilars are available, when will you prescribe them?
06 Aug 2017 Social RheumNow Wk in Review is up! FDA hearings on sirukumab, tofacitinib. iTUNES, podcast https://t.co/rX1zLRHUuA & video https://t.co/slvfTJYR1E
03 Aug 2017 News Arthritis Advisory Panel Votes Down Sirukumab
02 Aug 2017 Social FDA Arthritis Advisory Panel votes against (12-2) approval of Sirukumab (IL6 inhib) for use in RA. FDA decision pending.
31 Jul 2017 Social RheumNow Wk in Review is up! Cush talks to new FDA/EMA actions (baricitinib, belimumab, ABA), biosimilar costs, etc https://t.co/o3UHaFVuzd
28 Jul 2017 News NEJM: Actemra Effective in Giant Cell Arteritis
25 Jul 2017 News Baricitinib Derailed by FDA Review
24 Jul 2017 Slide of the day Biosimilar Survey Results from Rheumatologists and Patients
24 Jul 2017 Social Samsung Bioepis launches U.S. sales of Remicade biosmiliar- Renflexis https://t.co/emo6Te0yyW
24 Jul 2017 News Rheumatologists and Patients Concerns over Biosimilars - RheumNow “Live Vote” Results